“We are delighted to welcome David with his extensive experience in financial strategy as part of our team. He will be a valuable asset as he is ideally suited to the role that requires commercial acumen, analytical skills and an ability to build effective relationships”, said Dr. John McKeon
DUBLIN (PRWEB) September 01, 2020
In his role as Senior Finance Business Partner, David will liaise with the Chief Financial Officer and with the leadership team to drive company performance. His role will include assisting in the expansion of ASL’s financial reporting system and working closely with ASL’s partners in USA and Canada to grow the asthma & allergy friendly® Certification Program
“We are delighted to welcome David with his extensive experience in financial strategy as part of our financial team. He will be a valuable asset as he is ideally suited to the role that requires commercial acumen, analytical skills and an ability to build effective relationships”, said Dr. John McKeon, CEO.
David has worked for multinationals in financial technology and the telecommunication sectors. He has extensive experience managing financial teams in Europe and North America. Throughout his career, David has demonstrated excellence in preforming in-depth financial planning and analysis, employing a practical mindset that encompasses a range of statistical analytical techniques. He has a strong track record in financial reporting, budgeting, planning and analysis and has much experience in coordinating with CEOs, legal and account managers in developing new business opportunities and producing high quality/value information.
His ability to provide targeted strategic insights will ensure key operational, commercial and financial targets are delivered. David’s strong record on providing analysis and delivering insights that link financial reports to business strategies will enable him to drive Allergy Standards forward in this rapidly changing environment.
David graduated from the Robert Gordon University (Aberdeen, UK) with a Bachelor of Science, Forensic Science and Law. Following this, he went on to be awarded a Master of Science, Quantitative Genetics & Genome Analysis at the University of Edinburgh. Subsequently, he became a chartered accountant at the London School of Business and Finance.
“It’s great to join such an ambitious team with a clear vision of the future. I look forward to working with our partners across the world to help grow the asthma & allergy friendly® Certification Program and ASL”, said David.
About Allergy Standards
Allergy Standards Limited (ASL) mantra is design thinking and an innovation for healthier indoor air for the allergy aware consumer. As an independent, international certification company, it creates meaningful scientific standards for testing a wide range of products and services to determine their impact on improving indoor air quality. ASL’s intellectual property portfolio includes unique testing protocols and suitability specifications for products to be CERTIFIED asthma & allergy friendly®. ASL’s mission is to improve lives by empowering people create the healthiest possible indoor environment through science, education and innovation. Our vision is a world where all ER visits caused by exposure to avoidable indoor allergens are eliminated.